UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000013663
Receipt number R000015376
Scientific Title The randomized controlled crossover clinical trial of Red Koji (Red Mold Rice) in the serum lipid-improvement with dietary therapy for prevention of atherosclerosis
Date of disclosure of the study information 2014/04/08
Last modified on 2020/10/12 12:12:40

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The randomized controlled crossover clinical trial of Red Koji (Red Mold Rice) in the serum lipid-improvement with dietary therapy for prevention of atherosclerosis

Acronym

The randomized controlled crossover clinical trial of Red Koji (Red Mold Rice) with dietary therapy

Scientific Title

The randomized controlled crossover clinical trial of Red Koji (Red Mold Rice) in the serum lipid-improvement with dietary therapy for prevention of atherosclerosis

Scientific Title:Acronym

The randomized controlled crossover clinical trial of Red Koji (Red Mold Rice) with dietary therapy

Region

Japan


Condition

Condition

Dyslipidemia

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Examine the serum lipid improving effect as well as safety of proper use of Red Koji as a dietary supplement under control of medical management.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Change of LDL-C from the baseline to 4 and 8 weeks with Red Koji

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Dietary therapy+Red Koji ->(washout period) -> Dietary therapy

Interventions/Control_2

Dietary therapy -> (washout period) -> Dietary therapy+Red Koji

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

1)People with LDL-cholesterol level of 140 and over mg/dL without the past of a coronary artery disease
2)patients under an enforcement schedule or enforcement of dietary therapy for hypercholesterolemia
3)Age >=20 years, <80 years (Male and Female)
4)A consent form for participating in this study is submitted

Key exclusion criteria

1)Patients with familial hypercholesterolemia or with LDL-cholesterol level of 180 and over mg/dL
2)People with rice allergy, and people who have resistance in eating rice
3)Patients taking statin drugs within 4 weeks (or Probucol within 8 weeks) in the past
4)Patients with type 1 diabetes or diabetic patients with HbA1c level of over 8%
5)Patients with sever diseases other than diabetes, such as liver disease, a renal disease, and cardiac disease
6)Patients with the past, such as a food allergy, idiosyncrasy, and alcoholism
7)People who participated in other clinical trials within the past three months before the start of this clinical trial, or who have participated in other clinical trials at the start of this clinical trial
8)Patients who are pregnant, breastfeeding or intention to becoming pregnant
9)Patients whose LDL-cholesterol level became less than 140 mg/dL by dietary therapy of period I or patients with TG level of 400 and over mg/dL
10)Patients judged unsuitable by the investigator.

Target sample size

16


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hiroshi Mabuchi

Organization

Kanazawa University Graduate School of Medical Sciences

Division name

Department of Lipidology

Zip code


Address

13-1 Takaramachi, Knazawa, 920-8640

TEL

076-265-2000

Email

mabuchi@med.kanazawa-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Atsushi Nohara

Organization

Kanazawa University Graduate School of Medical Sciences

Division name

Department of Lipidology

Zip code


Address

13-1 Takaramachi, Knazawa, 920-8640

TEL

076-265-2000

Homepage URL


Email

a-nohara@med.kanazawa-u.ac.jp


Sponsor or person

Institute

Kanazawa University Graduate School of Medical Sciences

Institute

Department

Personal name



Funding Source

Organization

Kanazawa University Graduate School of Medical Sciences

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2014 Year 04 Month 08 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2014 Year 02 Month 25 Day

Date of IRB

2014 Year 03 Month 27 Day

Anticipated trial start date

2014 Year 04 Month 17 Day

Last follow-up date

2015 Year 10 Month 25 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2014 Year 04 Month 07 Day

Last modified on

2020 Year 10 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015376


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name